卒中患者机械取栓中经桡动脉与经股动脉入路的非劣效性随机临床试验
该研究者发起的单中心、评估者盲法非劣效性随机临床试验纳入120例大血管闭塞卒中拟行机械取栓患者,按1:1随机分配至经桡动脉或经股动脉入路。意向性分析116例中,经桡动脉组成功再通56/58(96.6%),经股动脉组51/58(87.9%),校正单侧风险差-5.0%(95%CI,-6.61%至+13.1%),显示经桡动脉非劣效;但经桡动脉组从到达导管室至首次通过及至再通的时间均更长。
要点
- 经桡动脉入路在最终成功再通方面非劣效于经股动脉入路。
- 经桡动脉组从到达导管室至首次通过时间中位数41分钟,长于经股动脉组的30分钟(P<0.001)。
- 经桡动脉组从到达导管室至再通时间中位数59.5分钟,长于经股动脉组的42分钟(P<0.050)。
核心结论
- 在接受机械取栓的患者中,经桡动脉入路在最终再通方面非劣效于经股动脉入路。
- 操作延迟可能支持将经股动脉入路作为默认的一线入路。
研究设计与样本
- 研究者发起的单中心、评估者盲法非劣效性随机临床试验,纳入股动脉通畅且桡动脉直径≥2.5 mm的卒中机械取栓患者。
- 2021年9月至2023年7月随机分配120例患者(经桡动脉60例、经股动脉60例),其中116例(经桡动脉58例、经股动脉58例)初始血管造影确认颅内闭塞并纳入意向性分析。
- 主要二分类结局为盲法评估者判定的成功再通(扩展脑缺血治疗评分2b-3),非劣效界值为-13.2%。
主要发现
- 经股动脉组成功再通51/58(87.9%),经桡动脉组56/58(96.6%),校正单侧风险差-5.0%(95%CI,-6.61%至+13.1%),显示经桡动脉非劣效。
- 从到达导管室至首次通过时间中位数:经股动脉组30分钟(四分位距25-37)vs 经桡动脉组41分钟(四分位距33-62),P<0.001。
- 从到达导管室至再通时间中位数:经股动脉组42分钟(四分位距28-74)vs 经桡动脉组59.5分钟(四分位距44-81),P<0.050。
- 两组各出现1例严重入路并发症,入路转换率无差异:经桡动脉7例(12.1%)vs 经股动脉5例(8.6%),P=0.751。
关键数值与推荐
- 非劣效界值为-13.2%,基于预期再通率可接受降低15%设定。
- 成功再通定义为扩展脑缺血治疗评分2b-3。
- 入组条件为股动脉通畅且桡动脉直径≥2.5 mm。
临床怎么用
- 作者认为,经桡动脉入路在最终再通方面非劣效于经股动脉入路。
- 作者指出,操作延迟可能支持将经股动脉入路作为默认的一线入路。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transfemoral access is predominantly used for mechanical thrombectomy in patients with stroke with a large vessel occlusion. Following the interventional cardiology guidelines, routine transradial access has been proposed as an alternative, although its safety and efficacy remain controversial. We aim to explore the noninferiority of radial access in terms of final recanalization. METHODS: The study was an investigator-initiated, single-center, evaluator-blinded, noninferiority randomized clinical trial. Patients with stroke undergoing mechanical thrombectomy, with a patent femoral artery and a radial artery diameter ≥2.5 mm, were randomly assigned (1:1) to either transradial (60 patients) or transfemoral access (60 patients). The primary binary outcome was the successful recanalization (expanded Treatment in Cerebral Ischemia score, 2b-3) assigned by blinded evaluators. We established a noninferiority margin of -13.2%, considering an acceptable reduction of 15% in the expected recanalization rates. RESULTS: From September 2021 to July 2023, 120 patients were randomly assigned and 116 (58 transradial access and 58 transfemoral access) with confirmed intracranial occlusion on the initial angiogram were included in the intention-to-treat analysis. Successful recanalization was achieved in 51 (87.9%) patients assigned to transfemoral access and in 56/58 (96.6%) patients assigned to transradial (adjusted 1 side risk difference [RD], -5.0% [95% CI, -6.61% to +13.1%]) showing noninferiority of transradial access. Median time from angiosuite arrival to first pass (femoral, 30 [interquartile range, 25-37] minutes versus radial: 41 [interquartile range, 33-62] minutes; P<0.001) and from angiosuite arrival to recanalization (femoral: 42 (IQR, 28-74) versus radial: 59.5 (IQR, 44-81) minutes; P<0.050) were longer in the transradial access group. Both groups presented 1 severe access complication and there was no difference in the rate of access conversion: transradial 7 (12.1%) versus transfemoral 5 (8.6%) (P=0.751). CONCLUSIONS: Among patients who underwent mechanical thrombectomy, transradial access was noninferior to transfemoral access in terms of final recanalization. Procedural delays may favor transfemoral access as the default first-line approach. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT05225636.
引用
- Hernandez D, Requena M, Olivé-Gadea M, et al. Radial Versus Femoral Access for Mechanical Thrombectomy in Patients With Stroke: A Noninferiority Randomized Clinical Trial. Stroke. 2024. PMID: 38299334. doi:10.1161/STROKEAHA.124.046360
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。